Voyager Therapeutics, Inc. (VYGR) › RevenueVoyager Therapeutics, Inc. (VYGR) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $14.22M2017: $10.13M2018: $7.62M2019: $104.39M2020: $171.13M2021: $37.41M2022: $40.91M2023: $250.01M2024: $80.00M2025: $40.37M$40.37M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$40.37M-49.5%2024$80.00M-68.0%2023$250.01M+511.2%2022$40.91M+9.3%2021$37.41M-78.1%2020$171.13M+63.9%2019$104.39M+1270.1%2018$7.62M-24.8%2017$10.13M-28.7%2016$14.22M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share